LTGO-33 is a novel NaV1.8 inhibitor with a unique mechanism of action

Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action